Prednisone and Halaven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisone (prednisone) and Halaven (eribulin mesylate). Common drug interactions include neuropathy peripheral among females.

The phase IV clinical study analyzes what interactions people have when they take Prednisone and Halaven. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Halaven?

Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

17 people who take Prednisone and Halaven together, and have interactions are studied.

Prednisone and Halaven drug interactions.

What are the common drug interactions of Prednisone and Halaven, by gender? *:

female:

Neuropathy peripheral (surface nerve damage)
Trigger finger
Febrile neutropenia (fever with reduced white blood cells)
Hypertrophic cardiomyopathy (a condition in which the heart muscle becomes abnormally thick)
Malignant neoplasm progression (cancer tumour came back)
Nausea (feeling of having an urge to vomit)
Neoplasm progression (growth of tumour)
Pulmonary embolism (blockage of the main artery of the lung)
Purpura (purplish discoloration of the skin)
Rash

male:

n/a

What are the common drug interactions of Prednisone and Halaven, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death

50-59:

Febrile neutropenia (fever with reduced white blood cells)

60+:

Neuropathy peripheral (surface nerve damage)
Trigger finger
Pulmonary embolism (blockage of the main artery of the lung)
Purpura (purplish discoloration of the skin)
Rash
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Vascular purpura (haemorrhages in the skin and mucous membranes that result in the appearance of purplish spots or patches)
Lung infection
Respiratory failure (inadequate gas exchange by the respiratory system)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)

What are the existing conditions these people have? *

Breast Cancer: 11 people, 64.71%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 52.94%
Cryoglobulinaemia (blood contains large amounts of cryoglobulins - proteins): 9 people, 52.94%
Neuralgia (pain in one or more nerves): 9 people, 52.94%
Breast Cancer Metastatic: 4 people, 23.53%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 11.76%
Itching: 2 people, 11.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%
Dyspnea (difficult or laboured breathing): 1 person, 5.88%
Depression: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and Halaven?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously